ArticleInternal and emergency medicine2022

"SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series" comment.

Dimitrios Patoulias et al.PubMed ↗Publisher ↗

No numbers read from the abstract.